Clinical Trial: An Open-Label, Phase I Clinical Trial of Super CAR-T With GPC3-Positive Advanced Hepatocellular Carcinoma

U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT07493044) titled 'An Open-Label, Phase I Clinical Trial of Super CAR-T With GPC3-Positive Advanced Hepatocellular Carcinoma' on March 19.

Brief Summary: This study was a phase I safety and tolerability clinical trial conducted in a single-center, open-label, 3+3 design with dose escalation.

Study Start Date: March 20

Study Type: INTERVENTIONAL

Condition: Advanced Hepatocellular Carcinoma (HCC) GPC3 Positive Hepatocellular Carcinoma

Intervention: BIOLOGICAL: Super CAR-T

All participators received lymphoid-depleted preconditioning before Super CAR-T cells infusion.

Super CAR-T cells were infused 3 days later.

Recruitment Status: RECRUITING

S...